Trial intelligence / Profile preview

Aloe Vera Juice for Chemotherapy and Radiation-induced Mucositis

NCT05369234Phase 3Completed

Sponsor
Thompson Cancer Survival Center
Start
Jan 2022
Primary completion
Jan 2024
Countries
1
01

Overview

Phase 3, randomised, single-blind trial (4 cohorts), sponsored by Thompson Cancer Survival Center. Primary endpoints: Prevention of Oral Mucositis and Esophagitis at 10 weeks and Management of Oral Mucositis and Esophagitis at 10 weeks. Started Jan 2022; status: completed.

Beyond the preview

Go deeper on NCT05369234.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05369234.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call